Loon Op Zand, Netherlands

Adrianus Petrus De Man

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Akzo Nobel N.v.. Active years: 1999-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adrianus Petrus De Man. Retrieved from https://idiyas.com/inventor/adrianus-petrus-de-man

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Adrianus Petrus De Man: Innovator in Thrombin Inhibition

Introduction

Adrianus Petrus De Man is a notable inventor based in Loon Op Zand, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the development of thrombin inhibitors. With a total of 2 patents to his name, De Man's work has implications for medical advancements and therapeutic applications.

Latest Patents

Among his latest patents, De Man has focused on serine protease inhibitors, specifically thrombin inhibitors. His invention relates to a thrombin inhibitor of the formula that showcases innovative approaches to managing blood coagulation and related disorders.

Career Highlights

De Man is associated with Akzo Nobel N.V., a leading global company in the field of paints and coatings. His role at the company has allowed him to leverage his expertise in biochemistry to contribute to groundbreaking research and development projects.

Collaborations

Throughout his career, De Man has collaborated with esteemed colleagues such as Anton Egbert Adang and Peter Diederik Grootenhuis. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new technologies.

Conclusion

Adrianus Petrus De Man stands out as a significant figure in the realm of thrombin inhibition, with his patents paving the way for future advancements in medical science. His contributions reflect a commitment to innovation and collaboration in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…